Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

3D-Printed Mucoadhesive Hydrogel Buccal Films Based on HPMC and Carbopol Bioinks Incorporating Cyclodextrin-Cannabinoid Complexes and Terpenes.

Gels (Basel, Switzerland)·2026

Same author

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement.

AAPS PharmSciTech·2026

Same author

All Roads Lead to Carbinolamine: QM/MM Study of Enzymatic C-N Bond Cleavage in Anaerobic Glycyl Radical Enzyme Choline Trimethylamine-Lyase (CutC).

The journal of physical chemistry. B·2025

Same author

Molecular Crosstalk and Therapeutic Synergy: Tyrosine Kinase Inhibitors and Cannabidiol in Oral Cancer Treatment.

Current issues in molecular biology·2025

Same author

Prognostic Factors in Patients Diagnosed with Gallbladder Cancer over a Period of 20 Years: A Cohort Study.

Cancers·2024

Same author

Sustainable Aquafeed Formulations Containing Insect Larval Meal and Grape Marc for the New Zealand Farmed Abalone.

Aquaculture nutrition·2023

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

Solid lipid nanoparticles for ocular drug delivery.

Ali Seyfoddin¹, John Shaw, Raida Al-Kassas

¹University of Auckland, Faculty of Medical and Health Sciences, School of Pharmacy, Auckland, New Zealand.

|May 25, 2010

Summary

Solid lipid nanoparticles (SLNs) offer a promising solution for ocular drug delivery, enhancing bioavailability and reducing toxicity. This review details SLN production, characterization, and application for improved eye treatments.

More Related Videos

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Related Experiment Videos

Last Updated: Jun 12, 2026

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Area of Science:

Pharmaceutical Sciences
Nanotechnology
Ophthalmology

Background:

Ocular drug delivery faces challenges due to the eye's complex structure, with conventional methods showing inefficiency and systemic routes causing toxicity.
Novel carriers are needed to improve ocular bioavailability and reduce cytotoxicity.
Nanotechnology presents a revolutionary approach to ocular drug delivery.

Purpose of the Study:

To review the production, characterization, sterilization, and stabilization techniques of solid lipid nanoparticles (SLNs) for ocular drug delivery.
To critically evaluate SLNs as a potential carrier system for ocular preparations.
To summarize existing studies on SLNs in ocular drug delivery.

Main Methods:

Detailed review of SLN production and characterization methods.
Explanation of in-vitro and in-vivo drug release studies for SLNs.
Focus on lipids and surfactants used in SLN formulation.
Discussion of autoclave sterilization suitability for ocular preparations.

Main Results:

SLNs are non-toxic, biocompatible carriers derived from physiological lipids.
SLNs enhance corneal drug absorption and improve ocular bioavailability for both hydrophilic and lipophilic drugs.
SLNs are amenable to autoclave sterilization, a crucial requirement for ophthalmic formulations.

Conclusions:

Solid lipid nanoparticles (SLNs) demonstrate significant potential as an advanced drug delivery system for ocular applications.
SLNs offer advantages in enhancing drug efficacy and patient safety compared to conventional methods.
Further research and development of SLNs are warranted to fully realize their therapeutic benefits in ophthalmology.